Safety and Efficacy of Gliflozin Group Among Patients with Type 2 Diabetes Including Patient’s Satisfaction in Saudi Arabia

Journal Title: Biomedical Journal of Scientific & Technical Research (BJSTR) - Year 2019, Vol 18, Issue 4

Abstract

Introduction: Sodium-Glucose Co-transporter 2 (SGLT2) inhibitors is the newest class of oral hypoglycemic agents that was approved for the management of patients with T2DM. Gliflozin group (Empagliflozin, Dapagliflozin & Canagliflozin) have a unique mechanism of action in reducing hyperglycemia by decreasing renal glucose reabsorption and promoting urinary glucose excretion. The aim of this research is to monitor and evaluate the clinical efficacy and safety of (SGLT2) inhibitors for the treatment of type 2 diabetes. Methodology: This study is a prospective cohort study supported by a questionnaire conducted by patients’ interview. Patients’ lab results were taken at baseline and 3-6 months later. This study, also, compared between two groups of patients; (26 patients) on Dapagliflozin and (23 patients) on Empagliflozin to compare the difference between their effects on HbA1c, FBG, Weight, BMI, LDL, HDL, TG, and total cholesterol. Result: Treatment with gliflozin group resulted in a significant reduction on HbA1c by (1%), FBG by (2.77 mmol/l) and BMI by (0.56 kg/m2 ) over 3 to 6 months. On the other hand, there was no significant difference in the comparison between Dapagliflozin and Empagliflozin group. During Ramadan month (46.2%) of the patients were very satisfied by the effect of gliflozin group, furthermore, no serious side effects were reported this month. Conclusion: Gliflozin group was generally well tolerated, no serious side effect or hypoglycemic events have been reported during or after Ramadan. Empagliflozin have a favorable effect in reducing HbA1c and FBG over Dapagliflozin. However, Dapagliflozin has a better influence on weight reduction.Subject of this study are susceptible to hypoglycemia especially in Ramadan month or fasting days. Also, the rate of night urination in this population is higher which may make them more liable to volume depletion. Additionally, type 2 diabetes patients need to manage their weight to maintain a good glucose control. Compliance and tolerance are always a challenge in patients with chronic disease. Gliflozin group have the following characteristics: a. Less hypoglycemic side effect; b. A positive effect on weight reduction; c. Help in controlling the glucose level; d. Tolerable with no serious side effects. Empagliflozin have a favor effect in reducing HbA1c and FBG over Dapagliflozin. However, Dapagliflozin have a better influence on weight reduction in comparison to Empagliflozin. During Ramadan month (46.2%) of the patients were very satisfied from the effect of gliflozin group. Due to the unique properties of gliflozin group in weight reduction and low risk of hypoglycemia, all these findings make gliflozin group a better choice for obese patients and who are at risk of hypoglycemia. Therefore, in comparison to other hypoglycemic agents as sulfonylureas and insulin therapy, which induce hypoglycemia and weight gain, consider the best option in diabetes treatment.

Authors and Affiliations

Al Hejji R, Al Ghamdi M, Al Haqbani D, Al Anazi B, Al Bajjal S, Al Ghadeer A, Al Najjar A, Al Suwaidan S

Keywords

Related Articles

A Case report: Importance of Molecular Allergy Diagnostics in Hen’s Egg Allergy

Background: Egg allergy is common in children. Most of the allergy outgrown with age. Oral food challenge (OFC) has been used in allergy diagnostics. Reference values within which 95% of the subjects with positive exposu...

Oral Candidiasis Susceptibility of Mice Lacking Interferon Regulatory Factor 3, A Preliminary Report

The purpose of this research was to evaluate the significance of interferon regulatory factors 3 to the susceptibility of oral candidiasis in mice. Materials and Methods: IRF-3KO and C57BL/6 mice were injected with cort...

Effect of Ethanolic Extract of Different Parts of Plant (Annona Squamosa) on the Fertility of Male Rats

Plants, since ancient times, have been used globally across the civilizations as valuable, safe and natural agents of therapeutic, industrial and environmental utilities. From the inception of civilization, humans have r...

Clinico-radiological Presentations of Maxillofacial Hard-Tissue Swellings in a Tertiary Health Facility in West African Suburb

Aims and Objectives: To study the prevalence of jaw swellings among maxillofacial surgery patients, the demographics of the patients with jaw swellings and the radiological characteristics of these jaw swellings seen ove...

Ascitic Type of Abdominal Tuberculosis in a 40 Year Old Female

Disseminated tuberculosis can cause a lot of damage to an individual if there is no early diagnosis. In Africa, about 70% of patients with abdominal tuberculosis present with ascites and most of these cases are missed di...

Download PDF file
  • EP ID EP621855
  • DOI 10.26717/BJSTR.2019.18.003173
  • Views 155
  • Downloads 0

How To Cite

Al Hejji R, Al Ghamdi M, Al Haqbani D, Al Anazi B, Al Bajjal S, Al Ghadeer A, Al Najjar A, Al Suwaidan S (2019). Safety and Efficacy of Gliflozin Group Among Patients with Type 2 Diabetes Including Patient’s Satisfaction in Saudi Arabia. Biomedical Journal of Scientific & Technical Research (BJSTR), 18(4), 13708-13714. https://europub.co.uk/articles/-A-621855